• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    EBMT-EHA
    CAR T-Cell Meeting
    2019
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

Decitabine

2:38
MPN updates: personalized prognostication, novel treatments & more
Ruben Mesa
1:48
A new era for elderly AML patients
Farhad Ravandi
3:32
Venetoclax in AML updates: approval & combinations
Marina Konopleva
5:06
Personlized therapy for MDS: Advancements and the future
Torsten Haferlach
2:45
Identifying genetic mutations for diagnosing MDS
Torsten Haferlach
1:34
The importance of quickly spotting the signs of AML
Srdan Verstovsek
4:19
Intervening on time: how hypomethylating agents can prevent transition to AML
Srdan Verstovsek
3:05
Current research in elderly, untreated AML: venetoclax combinations
Marina Konopleva
2:57
Genetic biomarkers of response to venetoclax in AML
Marina Konopleva
3:20
Venetoclax combinations effective in elderly AML
Marina Konopleva
1:39
Current landscape and future directions for lower-risk MDS treatment
David Steensma
1:06
Is there hope for treating TP53-mutated MDS?
Mark Levis
1:12
Hypomethylating agents for low risk MDS
Eunice Wang
1:58
Maintenance therapy strategies to reduce relapse in AML
Charles Craddock
2:50
Epigenetic therapies in AML: current and future landscape
Andrew Wei
1:54
Promising results for venetoclax across multiple hematological malignancies
Giovanni Martinelli
  • 1
  • 2
  • 3
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use